| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.24 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |